Acute pancreatitis after long-term therapy with mesalazine, and hyperamylasaemia associated with azathioprine in a patient with ulcerative colitis [3]

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 8, 2003, Pages 933-934

  Toubanakis, Christos ^a   Batziou, Ekaterini ^a   Sipsas, Nikolaos ^a   Galanopoulos, George ^a   Tzivras, Michael ^a   Archimandritis, Athanasios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MESALAZINE; METRONIDAZOLE; SALAZOSULFAPYRIDINE;

ACUTE PANCREATITIS; ADULT; CASE REPORT; CHRONIC DISEASE; COLITIS; DRUG INDUCED DISEASE; HUMAN; LETTER; LONG TERM CARE; MALE; PANCREATITIS; PRIORITY JOURNAL; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 0042315309     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200308000-00019     Document Type: Letter

References (12)

1. Dew MJ, Hughes AD, Williams G, Evans BK, Rhodes J. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. BMJ 1982; 285:1012.
2. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111:641-649.
3. Suryapranta H, De Vrie H. Pancreatitis associated with sulphasalazine. BMJ 1986; 293:732.
4. Sachedina B, Saibil F, Cohen LB, Whittey J. Acute pancreatitis due to 5-aminosalicylate. Ann Intern Med 1989; 110:490-492.
5. Deprez P, Descamps CH, Fiasse R. Pancreatitis induced by 5-aminosalicylic acid. Lancet 1989; ii:445-446.
6. Fiorentini MT, Fracchia M, Galatola G, Barlotta A, De La Pierre M. Acute pancreatitis during oral 5-aminosalicylic acid therapy. Dig Dis Sci 1990; 35:1180-1182.
7. Fernandez J, Sala M, Panes J, Feu F, Navarro S, Teres J. Acute pancreatitis after long term 5-aminosalicylic acid therapy. Am J Gastroenterol 1997; 92:2302-2303.
8. Adachi E, Okazaki K, Matsushima Y, Seno H, Uchida K, Nakase H, et al. Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis. Int J Pancreatol 1999; 25:217-221.
9. Marion JF. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease. Inflamm Bowel Dis 1998; 4:116-117.
10. Lamers CBHW, Griffioen G, Van Hogenzand RA. Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease. Scand J Gastroenterol 1999; 34 (suppl 230):111-115.
11. Castiglione F, Del Vecchio Blanco G, Rispo A, Mazzaca G. Prevention of pancreatitis by weekly amylase assay in patients with Crohn's disease treated with azathioprine. Am J Gastroenterol 2000; 95:2394-2395.
12. Glintborg B. Pancreatitis in a patient with Crohn's disease treated with mesalamine and azathioprine. Ugeskr Laeger 2000; 162:4553-4554.